Ticker | OMC | Earnings Date | July 28, 2026 (After Market Close) |
Reporting Period | Q2 2026 (2QFY-2026) | Last Earnings | April 28, 2026 (Q1 2026) |
Sector ETF | S&P 500 (SPY) | Prepared | July 27, 2026 |
Key Takeaway: Setup is modestly constructive — consensus sits at a beatable bar on organic growth (~3.6% vs. management's full-year 4% target) and EPS (~$2.61), with the biggest swing factor being the pace of IPG synergy flow-through and whether portfolio dispositions are tracking ahead of schedule.
Heading into Q2 2026, the bar for Omnicom looks achievable but not easy. Consensus organic revenue growth of ~3.6% sits modestly below management's full-year 4% constant-currency target, implying the Street is not fully pricing in an acceleration from Q1's 3.9% print — a slight cushion if integrated media continues its high-single-digit trajectory. Management's tone on the Q1 call was notably confident: Wren upgraded EPS language from generic "double digit" to "higher double digits than Q1" for remaining quarters, and the $900M synergy target for 2026 was reaffirmed with three-quarters to four-fifths expected to flow through to EBIT. Estimate revisions have been broadly stable since the Q1 print, with operating EPS consensus at ~$2.61 vs. the $2.63 baseline set five days post-Q1 — a negligible drift that suggests the Street is in a wait-and-see mode rather than building in upside. The stock has rallied ~7% since last earnings (vs. SPY +4%), trading at a low-double-digit P/E that still represents a meaningful discount to historical averages and to Publicis, leaving room for multiple re-rating if execution continues. The key wildcard is the Publicis/LiveRamp competitive dynamic: Publicis just reported Q2 with +4.8% organic growth and raised full-year guidance to 4.5–5%, directly challenging OMC's positioning — any commentary on client retention or new business momentum in the context of this competitive shift will be closely watched.
Key Takeaway: Consensus sets a modestly beatable bar on organic growth (~3.6% vs. 4% guidance) and operating EPS (~$2.61 vs. Q1's $1.90 beat). Integrated Media revenue is the bigger swing factor — if it sustains high-single-digit growth, total organic growth likely clears consensus; if it decelerates, the miss risk is real.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Guidance | Consensus vs. Guidance |
Total Revenue (Core Ops) | $6.24B | $5.79B | $6.07B ¹ | +4.8% YoY | ~4% organic (FY) | In line |
Total Revenue (Reported) | $6.24B | $4.02B | $6.44B ¹ | +60% YoY (IPG consolidation) | N/A (IPG distorts) | N/A |
Organic Revenue Growth YoY (%) | 3.9% (core) | 3.0% | 3.6% ¹ | +60 bps YoY | ~4% FY 2026 | -40 bps below guidance |
Diluted EPS — Operating | $1.90 | $2.05 | $2.61 ¹ | +27% YoY | "Higher double digits" vs. Q1 (+11.8%) | Tracking above guidance floor |
EBITDA — Operating | $862M | $602M | $1,212M ¹ | +101% YoY (IPG consolidation) | Margin expansion vs. combined basis | N/A (no explicit $ guidance) |
Integrated Media Revenue | $2.98B | N/A — new segment | $3.18B ¹ | N/A (new segment) | High single-digit growth (Q1 commentary) | ~+7% implied vs. Q1 |
Precision Marketing Revenue | $548M | $457M | $581M ¹ | +27% YoY | N/A (no explicit guidance) | N/A |
Advertising Revenue | $1.06B | N/A — new segment | $1.03B ¹ | N/A (new segment) | Declining (Q1 commentary) | Tracking with guidance |
¹ Source: Visible Alpha Consensus and Actuals Data. Core revenue consensus $6.07B; reported revenue consensus $6.44B; organic growth consensus 3.6%; operating EPS consensus $2.61; operating EBITDA consensus $1,212M; Integrated Media consensus $3.18B; Precision Marketing consensus $581M; Advertising consensus $1.03B. All as of July 27, 2026.
Top 2 KPIs: Organic Revenue Growth (%) and Diluted EPS — Operating ($)
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Organic Growth | 3.9% | 2.7% ¹ | +120 bps | Beat |
Q1 2026 | Op. EPS | $1.90 | $1.77 ¹ | +7.3% | Beat |
Q4 2025 | Organic Growth | 2.9% | 3.0% ¹ | -10 bps | Miss |
Q4 2025 | Op. EPS | $2.59 | $2.66 ¹ | -2.6% | Miss |
Q3 2025 | Organic Growth | 2.6% | 2.7% ¹ | -10 bps | In Line |
Q3 2025 | Op. EPS | $2.24 | $2.14 ¹ | +4.7% | Beat |
Q2 2025 | Organic Growth | 3.0% | 2.8% ¹ | +20 bps | Beat |
Q2 2025 | Op. EPS | $2.05 | $1.99 ¹ | +3.0% | Beat |
Q1 2025 | Organic Growth | 3.4% | 3.7% ¹ | -30 bps | Miss |
Q1 2025 | Op. EPS | $1.70 | $1.64 ¹ | +3.7% | Beat |
Q4 2024 | Organic Growth | 5.2% | 4.7% ¹ | +50 bps | Beat |
Q4 2024 | Op. EPS | $2.41 | $2.37 ¹ | +1.7% | Beat |
Q3 2024 | Organic Growth | 6.5% | 5.2% ¹ | +130 bps | Beat |
Q3 2024 | Op. EPS | $2.03 | $2.00 ¹ | +1.5% | Beat |
Q2 2024 | Organic Growth | 5.2% | 4.4% ¹ | +80 bps | Beat |
Q2 2024 | Op. EPS | $1.95 | $1.92 ¹ | +1.6% | Beat |
¹ Source: Visible Alpha Consensus and Actuals Data. Consensus figures represent latest available consensus at time of reporting for each respective quarter.
Pattern: OMC has beaten operating EPS consensus in 7 of the last 8 quarters, with the lone miss in Q4 2025 driven by IPG integration costs; organic growth beats have been more mixed (5 beats, 3 misses/in-line), with the Street consistently underestimating growth in stronger macro environments.
Key Takeaway: Management's posture has shifted more confident since Q1 earnings — EPS language was upgraded from "double digit" to "higher double digits than Q1" for remaining quarters, and the $900M synergy target was reaffirmed. The only notable post-earnings development is the Publicis/LiveRamp announcement (May 17) which prompted Wren to accelerate the LiveRamp separation timeline by ~1 year, signaling competitive urgency around identity infrastructure.
Metric | Initial Guidance (Q1 2026 Call, Apr 28) | Revised Guidance | Current Consensus | Note |
FY 2026 Organic Revenue Growth | ~4% constant currency (core operations) | — | 3.7% ¹ | Unchanged; consensus slightly below guidance midpoint |
FY 2026 Operating EPS | "Double digit" YoY; remaining quarters "higher double digits than Q1" (+11.8%) | — | $10.77 ¹ | Upgraded language on Q1 call; implies >12% YoY growth for Q2-Q4 |
2026 Cost Synergies | $900M in 2026; $1.5B by mid-2028 | — | N/A | Reaffirmed; ~75-80% expected to flow through to EBIT |
Share Count Decline (FY 2026) | 11-12% decline vs. Dec 31, 2025 (313.4M shares); wtd avg -8-9% | — | N/A | Reaffirmed; $2.8B repurchased through Q1 via ASR + open market |
FX Impact (FY 2026) | ~+1% tailwind to reported revenue (assuming rates hold) | — | N/A | Unchanged; USD weakness since Q1 could provide incremental tailwind |
Tax Rate (FY 2026) | 26% (vs. 26.7% in 2025) | — | N/A | Unchanged |
LiveRamp Separation Timeline | Planned independence by ~2028 (prior guidance) | Accelerated to ~1 year from May 2026 conference (~mid-2027) | N/A | Accelerated post-Publicis/LiveRamp acquisition announcement (May 17, 2026); Acxiom Real ID positioned as replacement |
¹ Source: Visible Alpha Consensus and Actuals Data. FY 2026 organic growth consensus 3.7%; FY 2026 operating EPS consensus $10.77. As of July 27, 2026.
Key Takeaway: Estimates have been broadly stable to slightly lower since the Q1 print — Q2 organic growth consensus drifted down ~13 bps from the post-Q1 baseline while FY EPS slipped ~$0.05, suggesting the Street is not building in upside from synergy acceleration. The gap between consensus organic growth (~3.6% Q2, ~3.7% FY) and management's 4% target represents potential cushion if integrated media sustains momentum.
KPI (Period) | Estimate (May 5, 2026 — ~5 Days Post Q1) | Current Consensus | Estimate Delta (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Delta | Consensus vs. Guidance |
Organic Growth % (Q2 2026) | 3.50% ¹ | 3.63% ¹ | +13 bps | ~4% FY (no Q2-specific) | Unchanged | — | -37 bps below FY guidance |
Op. EPS (Q2 2026) | $2.63 ¹ | $2.61 ¹ | -0.8% | "Higher double digits" vs. Q1 (+11.8%) | Unchanged | — | +27% YoY; tracking above guidance floor |
Op. EBITDA (Q2 2026) | $1,195M ¹ | $1,212M ¹ | +1.4% | Margin expansion vs. combined basis | Unchanged | — | Tracking with guidance |
Organic Growth % (FY 2026) | 4.08% ¹ | 3.73% ¹ | -35 bps | ~4% constant currency | Unchanged | — | -27 bps below guidance; modest downward drift |
Op. EPS (FY 2026) | $10.83 ¹ | $10.77 ¹ | -0.6% | "Double digit" YoY growth | Unchanged | — | Tracking above guidance floor |
¹ Source: Visible Alpha Consensus and Actuals Data. Post-Q1 baseline (as of May 5, 2026) and current consensus (as of July 27, 2026). FY organic growth consensus drifted down 35 bps since the Q1 print, while FY EPS slipped ~$0.06 — a modest downward drift consistent with macro uncertainty rather than a fundamental re-rating.
Key Takeaway: OMC has underperformed SPY since Q1 earnings (+7.2% vs. +3.8% for SPY through July 28), with the stock's recovery driven primarily by synergy confidence and buyback execution rather than multiple expansion — the stock still trades at a meaningful discount to historical P/E and to Publicis, suggesting the market has not yet fully priced in integration upside.
OMC vs. S&P 500 (SPY) — Indexed to 100 at Q1 2026 Earnings (April 28, 2026). Source: Stock Price Data.
Key Takeaway: Peer read-throughs are net positive for OMC's Q2: Publicis delivered a strong Q2 beat and raised guidance, Google's ad revenue grew +14% with strength across all verticals, and Meta's ad impressions grew +19% — all pointing to a healthy advertising market. The key risk flag is IT/consulting softness (Publicis Sapient mid-single-digit decline, WPP's ongoing account losses) which could weigh on OMC's Precision Marketing segment.
Read-Through Signal: STRONG POSITIVE
Read-Through Signal: MIXED / NEGATIVE (WPP-specific; market conditions broadly stable)
Read-Through Signal: POSITIVE for ad market; neutral for agencies
Read-Through Signal: POSITIVE for ad market; limited direct agency read-through
Read-Through Signal: POSITIVE for programmatic/open internet; macro caution noted
Key Takeaway: The most important development since Q1 earnings is the Publicis acquisition of LiveRamp (May 17) — it directly threatens OMC's identity infrastructure and forced an accelerated separation timeline, but OMC's Acxiom Real ID positioning and existing LiveRamp contract through Q1 2028 limit near-term disruption. Analyst coverage initiations (Goldman Buy at $146, Rothschild Neutral at $89) reflect a wide range of views on integration execution risk.
Key Takeaway: No open-market buys or discretionary sells since Q1 earnings — all transactions are routine equity award grants (code A) and tax-withholding dispositions (code F). The large May 22 grants to Wren, Angelastro, and Simm reflect annual equity compensation, not discretionary buying. Nothing notable to flag.
Name | Title | Transaction Type | Shares | Date | Note |
John Wren | Chairman & CEO | Equity Award Grant (A) | 75,938 shares | May 22, 2026 | Annual equity compensation grant; not a discretionary purchase |
John Wren | Chairman & CEO | Tax Withholding Disposition (F) | 4,397 shares | May 15, 2026 | Shares withheld for tax obligation on vesting; not a discretionary sale |
Philip J. Angelastro | EVP & CFO | Equity Award Grant (A) | 48,818 shares | May 22, 2026 | Annual equity compensation grant; not a discretionary purchase |
Philip J. Angelastro | EVP & CFO | Tax Withholding Disposition (F) | 4,476 shares | May 15, 2026 | Shares withheld for tax obligation on vesting; not a discretionary sale |
Daryl Simm | Co-President & Co-COO | Equity Award Grant (A) | 54,242 shares | May 22, 2026 | Annual equity compensation grant; not a discretionary purchase |
Daryl Simm | Co-President & Co-COO | Tax Withholding Disposition (F) | 3,969 shares | May 15, 2026 | Shares withheld for tax obligation on vesting; not a discretionary sale |
Louis F. Januzzi | SVP, General Counsel & Secretary | Equity Award Grant (A) | 7,720 shares | July 16, 2026 | Equity compensation grant; not a discretionary purchase |
Louis F. Januzzi | SVP, General Counsel & Secretary | Tax Withholding Disposition (F) | 1,849 shares | May 15, 2026 | Shares withheld for tax obligation on vesting; not a discretionary sale |
Multiple Directors (10 individuals) | Board of Directors | Equity Award Grant (A) | ~703-1,013 shares each | July 1, 2026 | Routine annual director equity compensation grants; not discretionary purchases |
Source: Insider Transaction Data (SEC Form 4 filings). All transactions since April 28, 2026 (Q1 2026 earnings). No open-market buys (code P) or discretionary sells (code S) were filed in the period. All activity consists of equity award grants (code A — compensation) and tax-withholding dispositions (code F — obligation-driven). No 10b5-1 plan initiations were filed. Insider activity is entirely routine and provides no directional signal.
Analyst Consensus Summary (as of July 27, 2026): 4 Buy / 5 Hold / 1 Sell; average price target ~$99.38. Notable: Goldman Sachs Buy at $146 (June 3), Citigroup Buy at $105 (April 30), Rothschild Neutral at $89 (May 28), Morgan Stanley Equal Weight at $83 (May 1). Wide PT dispersion reflects genuine uncertainty around IPG integration execution and synergy realization timeline.